Among allogeneic hematopoietic cell transplant recipients, the use of sirolimus for graft-vs-host disease (GVHD) prophylaxis was linked to a higher risk for respiratory syncytial virus (RSV) infection ...

Retrospective longitudinal data (2013–2024) from six immunotherapy-naive MuSK-MG patients yielded 103 observations linking MuSK antibody levels to MG-ADL using generalized linear mixed-effects ...

Patients with elevated anti-HLA antibodies experienced significantly prolonged time to transplant — a median of 120 days ...

LOS ANGELES -- U.S. regulators issued new guidance this week shortening the time that people who received Moderna or Pfizer's COVID-19 vaccine have to wait for a booster, and it's different than the ...

Anti-BP180 antibody levels demonstrated a moderate to strong correlation with the severity of bullous pemphigoid (BP), in a meta-analysis highlighting the potential of anti-BP180 as a tool to monitor ...

Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six months later one stays healthy while the other contracts the virus. A new study ...

In British Columbia's Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study published in CMAJ ...

On Monday, Invivyd Inc. (NASDAQ:IVVD) shares rallied on the heels of a new data report involving a COVID-19 treatment. The company is conducting an ongoing Phase 1/2 trial of VYD2311, a monoclonal ...